Charles Schwab Investment Management Inc Alkermes Plc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,382,567 shares of ALKS stock, worth $69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,382,567

Previous 2,336,905 1.95%

Holding current value

$69 Million

Previous $63.3 Million 9.23%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$23.21 - $27.24 $1.06 Million - $1.24 Million	45,662 Added 1.95%	2,382,567 $57.4 Million
Q1 2024 May 08, 2024	BUY	$26.4 - $32.56 $5.01 Million - $6.18 Million	189,783 Added 8.84%	2,336,905 $63.3 Million
Q4 2023 Feb 06, 2024	SELL	$23.37 - $28.68 $352,326 - $432,379	-15,076 Reduced 0.7%	2,147,122 $59.6 Million
Q3 2023 Nov 08, 2023	BUY	$27.17 - $31.97 $3.11 Million - $3.66 Million	114,388 Added 5.59%	2,162,198 $60.6 Million
Q2 2023 Aug 09, 2023	BUY	$28.34 - $33.63 $2.81 Million - $3.33 Million	98,997 Added 5.08%	2,047,810 $64.1 Million
Q1 2023 May 11, 2023	SELL	$25.31 - $29.02 $561,628 - $643,953	-22,190 Reduced 1.13%	1,948,813 $54.9 Million
Q4 2022 Feb 13, 2023	BUY	$21.94 - $26.24 $1.02 Million - $1.23 Million	46,708 Added 2.43%	1,971,003 $51.5 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1.08 Million - $1.57 Million	49,206 Added 2.62%	1,924,295 $43 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $1.43 Million - $1.66 Million	-54,324 Reduced 2.82%	1,875,089 $55.9 Million
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $1.3 Million - $1.57 Million	56,188 Added 3.0%	1,929,413 $50.8 Million
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $1.32 Million - $1.97 Million	-61,454 Reduced 3.18%	1,873,225 $43.6 Million
Q3 2021 Nov 16, 2021	BUY	$23.37 - $32.13 $7.98 Million - $11 Million	341,464 Added 21.43%	1,934,679 $59.7 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $7.05 Million - $9.44 Million	375,454 Added 30.83%	1,593,215 $39.1 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $577,493 - $735,741	31,713 Added 2.67%	1,217,761 $22.7 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $288,393 - $414,131	18,739 Added 1.61%	1,186,048 $23.7 Million
Q3 2020 Nov 13, 2020	SELL	$16.16 - $20.66 $201,111 - $257,113	-12,445 Reduced 1.05%	1,167,309 $19.3 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $446,084 - $650,526	33,515 Added 2.92%	1,179,754 $22.9 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $23,011 - $37,424	-1,762 Reduced 0.15%	1,146,239 $16.5 Million
Q4 2019 Feb 07, 2020	BUY	$17.29 - $21.74 $899,131 - $1.13 Million	52,003 Added 4.74%	1,148,001 $23.4 Million
Q3 2019 Nov 08, 2019	BUY	$19.51 - $24.28 $6.54 Million - $8.14 Million	335,338 Added 44.09%	1,095,998 $21.4 Million
Q2 2019 Aug 09, 2019	BUY	$21.47 - $37.33 $1.11 Million - $1.94 Million	51,881 Added 7.32%	760,660 $17.1 Million
Q1 2019 May 14, 2019	BUY	$28.4 - $36.49 $2.56 Million - $3.29 Million	90,283 Added 14.6%	708,779 $25.9 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $748,512 - $1.2 Million	26,790 Added 4.53%	618,496 $18.3 Million
Q3 2018 Nov 13, 2018	BUY	$38.6 - $46.12 $946,008 - $1.13 Million	24,508 Added 4.32%	591,706 $25.1 Million
Q2 2018 Aug 08, 2018	BUY	$40.56 - $51.36 $1.23 Million - $1.56 Million	30,410 Added 5.67%	567,198 $23.3 Million
Q1 2018 May 07, 2018	BUY	$53.61 - $67.26 $2.32 Million - $2.91 Million	43,273 Added 8.77%	536,788 $31.1 Million
Q4 2017 Jan 17, 2018	BUY	$47.69 - $55.39 $1.13 Million - $1.31 Million	23,712 Added 5.05%	493,515 $27 Million
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $23.1 Million - $25.6 Million	469,803	469,803 $23.9 Million

Others Institutions Holding ALKS

# of Institutions

350

Shares Held

183M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.76B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Alkermes Plc. Transaction History